Drugmakers take hit from the US’ anti-vax changesBy Bhanvi Satija / Reuters, LONDONSweeping policy changes under US Secretary of Health and Human Services Robert F. Kennedy Jr are having a chilling effect on vaccine makers as anti-vaccine rhetoric has turned into concrete changes in inoculation schedules and recommendations, investors and executives said. He fired a panel of independent expert advisers, replacing them with members who share his anti-vaccine views, and dropped broad COVID-19 vaccine recommendations for pregnant women and children. Kennedy said the changes aim to improve safety and bring US vaccine policy in line with other peer nations. The striking policy changes have begun to prompt some rare public rebukes from industry leaders. GSK and Sanofi reported lower US flu vaccine sales in the third quarter, despite a more severe flu season.

Source: Taipei Times January 24, 2026 16:02 UTC